急性冠状动脉综合征患者强化他汀治疗专家共识

被引：118

作者：

霍勇 ^{[1
]}

葛均波 ^{[2
]}

韩雅玲 ^{[3
]}

王建安 ^{[4
]}

万征 ^{[5
]}

李建平 ^{[1
]}

钱菊英 ^{[2
]}

王斌 ^{[3
]}

项美香 ^{[4
]}

孙跃民 ^{[5
]}

代表急性冠状动脉综合征患者强化他汀治疗专家共识专家组

机构：

[1] 北京大学第一医院

[2] 复旦大学附属中山医院

[3] 沈阳军区总医院

[4] 浙江大学医学院附属第二医院

[5] 天津医科大学总医院

来源：

中国介入心脏病学杂志 | 2014年 / 22卷 / 01期

关键词：

急性冠状动脉综合征; 强化他汀治疗; 专家共识;

D O I：

暂无

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

100201 [内科学];

摘要：

<正>一、制定共识的必要性1.急性冠状动脉综合征和他汀类药物:急性冠状动脉综合征(acute coronary syndrome,ACS)是一组以急性心肌缺血为共同特征的临床综合征,包括不稳定型心绞痛(UA)、非ST段抬高心肌梗死(NSTEMI)和ST段抬高心肌梗死(STEMI)[1]。ACS主要发生机制为易损斑块破裂或溃疡合并血栓形成和(或)血管痉挛,引起冠状动脉狭窄程度急剧加重或急性闭塞[2]。ACS的罪犯病变通常

引用

页码：4 / 6

页数：3

共 19 条

[1]

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.[J].Michael V. Rocco.American Journal of Kidney Diseases.2012, 5

[2]

Effects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injury [J].

Yu, Xing Long ;

Zhang, Hai Juan ;

Ren, Shao Da ;

Geng, Jing ;

Wu, Ting Ting ;

Chen, Wen Qiang ;

Ji, Xiao Ping ;

Zhong, Lin ;

Ge, Zhi Ming .

CORONARY ARTERY DISEASE, 2011, 22 (02) :87-91

[3]

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials [J].

Sattar, Naveed ;

Preiss, David ;

Murray, Heather M. ;

Welsh, Paul ;

Buckley, Brendan M. ;

de Craen, Anton J. M. ;

Seshasai, Sreenivasa Rao Kondapally ;

McMurray, John J. ;

Freeman, Dilys J. ;

Jukema, J. Wouter ;

Macfarlane, Peter W. ;

Packard, Chris J. ;

Stott, David J. ;

Westendorp, Rudi G. ;

Shepherd, James ;

Davis, Barry R. ;

Pressel, Sara L. ;

Marchioli, Roberto ;

Marfisi, Rosa Maria ;

Maggioni, Aldo P. ;

Tavazzi, Luigi ;

Tognoni, Gianni ;

Kjekshus, John ;

Pedersen, Terje R. ;

Cook, Thomas J. ;

Gotto, Antonio M. ;

Clearfield, Michael B. ;

Downs, John R. ;

Nakamura, Haruo ;

Ohashi, Yasuo ;

Mizuno, Kyoichi ;

Ray, Kausik K. ;

Ford, Ian .

LANCET, 2010, 375 (9716) :735-742

[4]

Evidence of Pre-Procedural Statin Therapy.[J].David E. Winchester;Xuerong Wen;Lola Xie;Anthony A. Bavry.Journal of the American College of Cardiology.2010, 14

[5]

Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: Results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study [J].

Bi, Yufang ;

Gao, Runlin ;

Patel, Anushka ;

Su, Steve ;

Gao, Wei ;

Hu, Dayi ;

Huang, Dejia ;

Kong, Lingzhi ;

Qi, Wenhang ;

Wu, Yangfeng ;

Yang, Yuejin ;

Turnbull, Fiona .

AMERICAN HEART JOURNAL, 2009, 157 (03) :509-U7

[6]

Novel Approaches for Preventing or Limiting Events (Naples) II Trial.[J].Carlo Briguori;Gabriella Visconti;Amelia Focaccio;Bruno Golia;Alaide Chieffo;Alfredo Castelli;Marco Mussardo;Matteo Montorfano;Bruno Ricciardelli;Antonio Colombo.Journal of the American College of Cardiology.2009, 23

[7]

Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention.[J].Germano Di Sciascio;Giuseppe Patti;Vincenzo Pasceri;Achille Gaspardone;Giuseppe Colonna;Antonio Montinaro.Journal of the American College of Cardiology.2009, 6

[8]

The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.[J].Kyeong Ho Yun;Myung Ho Jeong;Seok Kyu Oh;Sang Jae Rhee;Eun Mi Park;Eun Mi Lee;Nam Jin Yoo;Nam-Ho Kim;Young Keun Ahn;Jin-Won Jeong.International Journal of Cardiology.2008, 3

[9]

Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial [J].